Fig. 4.
Changes in alcoholic liver disease and diabetes parameters in patients with diabetes and alcoholic liver disease receiving standard treatment alone (untreated) or with concomitant silymarin (treated) [59]. a Plasma malondialdehyde levels (a marker of membrane peroxidation); b glycosylated hemoglobin; c average daily insulin dose. aP < 0.05 vs. untreated control group; bP < 0.01 vs. untreated control group.
Reproduced with permission from Velussi et al. [59]